Literature DB >> 9293797

Quantitative bone metastases analysis based on image segmentation.

Y E Erdi1, J L Humm, M Imbriaco, H Yeung, S M Larson.   

Abstract

UNLABELLED: Preliminary evidence indicates that the fraction of bone containing metastatic lesions is a strong prognostic indicator of survival longevity for prostate and breast cancer. Our current approach to quantify metastatic bone lesions, called the Bone Scan Index, is based on an inspection of the bone scan, estimating visually the fraction of each bone involved and then summing across all bones to determine the percentage of total skeletal involvement. This approach, however, is time consuming, subjective and dependent on individual interpretation.
METHODS: To overcome these problems, a semiautomated image segmentation program was developed for the quantitation of metastases from planar whole-body bone scans. The user is required to insert a seed point into each metastatic region on the image. The algorithm then connects pixels to the seed pixel in all directions until a contrast-dependent threshold is reached. The optimal threshold for cessation of the region growing is determined from phantom studies. On the images, lesion delineation and size measurements were performed by the algorithm. Each delineated lesion is associated with a bone site using pull-down menus. The program then computes the fraction of lesion involvement in each bone based on look-up-tables containing the relationship of bone mass with race, sex, height and age. These look-up-tables were obtained by multiple regression of the skeletal mass measurements in humans. The total fraction of skeletal involvement is then obtained from the individual fractional masses. For individual fractional mass, values given in International Commission on Radiation Protection Publication No. 23 were used.
RESULTS: The bone metastases analysis system has been used on 11 scans from 6 patients. The correlation was high (r = 0.83) between conventional (manually drawn region-of-interest) and this analysis system. Bone metastases analysis results in consistently lower estimates of fractional involvement in bone compared with the conventional region-of-interest drawing or visual estimation method. This is due to the apparent broadening of objects at and below the limits of resolution of the gamma camera.
CONCLUSION: Image segmentation reduces the delineation and quantitation time of lesions by at least two compared with manual region-of-interest drawing. The objectivity of this technique allows the detection of small variations in follow-up patient scans for which the manual region-of-interest method may fail, due to performance variability of the user. This method preserves the diagnostic skills of the nuclear medicine physician to select which bony structures contain lesions, yet combines it with an objective delineation of the lesion.

Entities:  

Mesh:

Year:  1997        PMID: 9293797

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Authors:  David Ulmert; Reza Kaboteh; Josef J Fox; Caroline Savage; Michael J Evans; Hans Lilja; Per-Anders Abrahamsson; Thomas Björk; Axel Gerdtsson; Anders Bjartell; Peter Gjertsson; Peter Höglund; Milan Lomsky; Mattias Ohlsson; Jens Richter; May Sadik; Michael J Morris; Howard I Scher; Karl Sjöstrand; Alice Yu; Madis Suurküla; Lars Edenbrandt; Steven M Larson
Journal:  Eur Urol       Date:  2012-01-27       Impact factor: 20.096

2.  Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer.

Authors:  Vahé Barsegian; Stefan P Müller; Daniel Möckel; Peter A Horn; Andreas Bockisch; Monika Lindemann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-08       Impact factor: 9.236

3.  Computer-aided quantitative bone scan assessment of prostate cancer treatment response.

Authors:  Matthew S Brown; Gregory H Chu; Hyun J Kim; Martin Allen-Auerbach; Cheryce Poon; Juliette Bridges; Adria Vidovic; Bharath Ramakrishna; Judy Ho; Michael J Morris; Steven M Larson; Howard I Scher; Jonathan G Goldin
Journal:  Nucl Med Commun       Date:  2012-04       Impact factor: 1.690

4.  In situ study of the impact of inter- and intra-reader variability on region of interest (ROI) analysis in preclinical molecular imaging.

Authors:  Frezghi Habte; Shradha Budhiraja; Shay Keren; Timothy C Doyle; Craig S Levin; David S Paik
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

5.  Developing imaging strategies for castration resistant prostate cancer.

Authors:  Josef J Fox; Michael J Morris; Steven M Larson; Heiko Schöder; Howard I Scher
Journal:  Acta Oncol       Date:  2011-06       Impact factor: 4.089

Review 6.  Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management.

Authors:  Francois Rozet; Thierry Roumeguère; Martin Spahn; Dirk Beyersdorff; Peter Hammerer
Journal:  World J Urol       Date:  2016-03-17       Impact factor: 4.226

Review 7.  MET and VEGF: synergistic targets in castration-resistant prostate cancer.

Authors:  D T Aftab; D M McDonald
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

8.  Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

Authors:  Andrew J Armstrong; Reza Kaboteh; Michael A Carducci; Jan-Erik Damber; Walter M Stadler; Mats Hansen; Lars Edenbrandt; Göran Forsberg; Örjan Nordle; Roberto Pili; Michael J Morris
Journal:  Urol Oncol       Date:  2014-09-16       Impact factor: 3.498

9.  Relationship between tumor volume and quantitative values calculated using two-dimensional bone scan images.

Authors:  Shota Hosokawa; Kazumasa Inoue; Yasuyuki Takahashi; Kazunori Kawakami; Daisuke Kano; Yoshihiro Nakagami; Masahiro Fukushi
Journal:  Radiol Phys Technol       Date:  2017-10-05

Review 10.  Artificial intelligence applied to musculoskeletal oncology: a systematic review.

Authors:  Matthew D Li; Syed Rakin Ahmed; Edwin Choy; Santiago A Lozano-Calderon; Jayashree Kalpathy-Cramer; Connie Y Chang
Journal:  Skeletal Radiol       Date:  2021-05-19       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.